Swiss drug company Roche (SIX: ROG) has appointed Richard Erwin as the new UK general manager.
Mr Erwin joins Roche in the UK from his general manager role in Belgium/Luxembourg, where he worked with clinicians and the health service to ensure patient access. He joined the company 27 years ago in UK sales, marketing and clinical operations roles before moving into European and global leadership roles.
Mr Erwin said: “I am excited to be returning to Roche in the UK at a time when the government has announced its vision to make the UK the global leader in life sciences. Roche is the number one investor in healthcare research and development in the world, investing £6.2 billion [$9.52 billion] globally every year. We want to work closely with the UK government and the NHS to continue developing targeted medicines that meet the biggest areas of unmet need.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze